Neurocrine Biosciences, Inc.NBIXNASDAQ
Loading
Income Before Tax Over TimeExpanding
Percentile Rank100
3Y CAGR+48.8%
5Y CAGR+45.9%
Year-over-Year Change
Pre-tax earnings
3Y CAGR
+48.8%/yr
vs +76.9%/yr prior
5Y CAGR
+45.9%/yr
Consistent
Acceleration
-28.1pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
6.6x
Strong expansion
Streak
4 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $705.40M | +45.1% |
| 2024 | $486.00M | +46.3% |
| 2023 | $332.10M | +55.3% |
| 2022 | $213.90M | +110.9% |
| 2021 | $101.40M | -5.0% |
| 2020 | $106.70M | +129.5% |
| 2019 | $46.50M | +112.9% |
| 2018 | $21.84M | +115.3% |
| 2017 | $-142.54M | -1.0% |
| 2016 | $-141.09M | - |